Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simone Parello

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Best Practice & Research. Clinical Gastroenterology|December 5, 2025
Atherosclerotic cardiovascular disease and inflammatory bowel disease: epidemiology, pathogenesis and risk assessmentPierluigi Puca, Gaetano Coppola, Simone Parello, et al.
Journal of Gastrointestinal and Liver Diseases : JGLD|June 28, 2026
Bowel Urgency in Inflammatory Bowel Disease: Prevalence, Psychosocial Burden, and Challenges in AssessmentSimone Parello, Angelo Del Gaudio, Marco Murgiano, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|April 21, 2026
Interleukin-23 Inhibitors in Inflammatory Bowel DiseasePierluigi Puca, Simone Parello, Stefania Colantuono, et al.
International Journal of Molecular Sciences|April 17, 2025
Exploring the Role of Gut Microbiota and Probiotics in Acute Pancreatitis: A Comprehensive ReviewEnrico Celestino Nista, Simone Parello, Mattia Brigida, et al.
Minerva Gastroenterology|January 9, 2026
Mirikizumab effectiveness in a pregnant woman with acute severe ulcerative colitis: a case reportMarco Murgiano, Angelo Del Gaudio, Pierluigi Puca, et al.
Behavioral Sciences (Basel, Switzerland)|October 29, 2025
Exploring the Mediating Role of Self-Efficacy in the Relationship Between Caregiver Contribution and Resilience in Inflammatory Bowel DiseaseMattia Bozzetti, Ilaria Marcomini, Alessio Lo Cascio, et al.
Inflammatory Bowel Diseases|April 28, 2026
OCTN1 variants shape innate immunity and predict individual response to anti-TNFα in ulcerative colitis patients: An exploratory studyPierluigi Puca, Letizia Masi, Simone Parello, et al.
BMJ Open Gastroenterology|May 5, 2026
Effectiveness and safety of mirikizumab in ulcerative colitis: real-world data from the Latium NetMarco Murgiano, Paola Balestrieri, Emma Calabrese, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Best Practice & Research. Clinical Gastroenterology|December 5, 2025
Atherosclerotic cardiovascular disease and inflammatory bowel disease: epidemiology, pathogenesis and risk assessmentPierluigi Puca, Gaetano Coppola, Simone Parello, et al.
Journal of Gastrointestinal and Liver Diseases : JGLD|June 28, 2026
Bowel Urgency in Inflammatory Bowel Disease: Prevalence, Psychosocial Burden, and Challenges in AssessmentSimone Parello, Angelo Del Gaudio, Marco Murgiano, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|April 21, 2026
Interleukin-23 Inhibitors in Inflammatory Bowel DiseasePierluigi Puca, Simone Parello, Stefania Colantuono, et al.
International Journal of Molecular Sciences|April 17, 2025
Exploring the Role of Gut Microbiota and Probiotics in Acute Pancreatitis: A Comprehensive ReviewEnrico Celestino Nista, Simone Parello, Mattia Brigida, et al.
Minerva Gastroenterology|January 9, 2026
Mirikizumab effectiveness in a pregnant woman with acute severe ulcerative colitis: a case reportMarco Murgiano, Angelo Del Gaudio, Pierluigi Puca, et al.
Behavioral Sciences (Basel, Switzerland)|October 29, 2025
Exploring the Mediating Role of Self-Efficacy in the Relationship Between Caregiver Contribution and Resilience in Inflammatory Bowel DiseaseMattia Bozzetti, Ilaria Marcomini, Alessio Lo Cascio, et al.
Inflammatory Bowel Diseases|April 28, 2026
OCTN1 variants shape innate immunity and predict individual response to anti-TNFα in ulcerative colitis patients: An exploratory studyPierluigi Puca, Letizia Masi, Simone Parello, et al.
BMJ Open Gastroenterology|May 5, 2026
Effectiveness and safety of mirikizumab in ulcerative colitis: real-world data from the Latium NetMarco Murgiano, Paola Balestrieri, Emma Calabrese, et al.
Pageof 1